Clinical Trial Update: Cold Atmospheric Plasma Device Extension Study [Phase 3]

View source ↗

Summary

Phase 3 extension study of a cold atmospheric plasma device for verruca vulgaris and molluscum contagiosum was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Molluscum Contagiosum
• Verruca Vulgaris

Snippet

Sponsor: Medical University of South Carolina | Conditions: Verruca Vulgaris, Molluscum Contagiosum | Phase 3 | Status: TERMINATED